BBG Advanced Therapies collects first cell donation on one-of-a-kind bus

News

Adrienne B. Mendoza, Allogeneic Cell Therapies

The Donor Advantage: Why U.S. Starting Materials Are the Launchpad for Global Cell Therapy

September 23, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

What Europe taught Adrienne Mendoza about CGT access

Building Bridges: What Europe Just Taught Me About Scaling CGT Access

September 12, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Adrienne Mendoza Blueprint for breakthroughs: FDA's New Rare Disease Pathway and the future of CGT

Access in Advanced Therapies: How Regulatory Agility and Delivery Innovation Can Transform Patient Outcomes

September 9, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Blueprint For Breakthroughs: Adrienne Mendoza Rethinks How Advanced Therapies Can Be Scaled.

CGT Wake Up Call To Rethink How Advanced Therapies Scale

August 26, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

The blood bank and the future of cell & gene therapies. Blueprint for Breakthroughs.

The Blood Bank and the Future of Advanced Therapies

August 12, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Adrienne B Mendoza, Blueprint for breakthroughs, Potency Testing for advanced therapies

How Potency Testing Can Delay Advanced Therapies

August 12, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Potency Assays: The Key to Scalable Advanced Therapies

July 29, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Closing the Access Gap in Sarcoma Treatment Through Cell Therapy

July 15, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Designing for Reality: A Lesson From Architecture – and Advanced Therapies

July 15, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Adrienne Mendoza discusses how rethink the cleanroom can lead to breakthroughs while maintaining GMP quality

Rethinking Cleanroom Dependence in Advanced Therapies to Deliver as Personalized, Scalable, and Accessible

June 24, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Could access to gene and cell therapy and advanced therapies be built like the internet BluePrint for breakthroughs

Could Gene and Cell Therapy be Built Like the Internet?

June 4, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally

Guide to Decoupling Leukapheresis from Clinical Sites to Scale Out Access Blueprint for Breakthroughs

Breaking the Bottleneck to Clear Access to Cell and Gene Therapy

May 20, 2025

Blueprint for Breakthroughs is a LinkedIn newsletter published by Adrienne B. Mendoza, MHA, SVP BioBridge Global and Chief Operating Officer (COO), BBG Advanced Therapies Originally